Atlas Trials

The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer

Clinical trial NCT02262897 · UNKNOWN

Trial details

NCT number
NCT02262897
Sponsor
Tongji University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2013-09-01
Primary completion
2015-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.